The scale-up, promotion and use of oral pre-exposure prophylaxis (PrEP) in different settings and in different populations.

PrEP programmes and uptake: latest news

PrEP programmes and uptake resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales, Scotland and Northern Ireland, PrEP is available through NHS sexual health clinics.It...

    From: Factsheets

    Information level Level 2

PrEP programmes and uptake news from aidsmap

More news

PrEP programmes and uptake news selected from other sources

  • A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.

    A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients.

    14 May 2019 | The New York Times (editorial)
  • Generic HIV prevention drug coming in 2020, Gilead says

    "Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required," wrote Douglas Brooks, Gilead's executive director for community engagement, in an email shared with NBC News by the advocacy group PrEP4All.

    09 May 2019 | CNBC
  • Official Statement responding to Gilead Sciences’ announcement that it will allow Teva to Manufacture a Generic Version of Truvada

    While Gilead’s announcement that generic Truvada will be made available in the United States a year early is a victory for the LGBTQ+ community, for HIV activists, and for U.S. taxpayers, this should only be the beginning. Even their announcement today leaves Gilead with exclusive rights to Truvada as PrEP for another 15 months and Teva as the only generic manufacturer on the U.S. market. This will do little to reduce the price in a way that will increase access and PrEP4All remains suspicious of the terms and lack of transparency surrounding the Teva settlement.

    09 May 2019 |
  • How About Letting Nurses Provide PrEP to Patients?

    Because it’s so important to make sure that pre-exposure prophylaxis (PrEP) is available to people at risk of acquiring HIV, a team of investigators at the University of Ottawa in Ontario, Canada, has proposed that nurses be on the front lines of providing PrEP. Most current guidelines for PrEP are not written for non-prescribing clinicians such as nurses, even though they may be uniquely positioned to assess patients and recommend PrEP.

    03 May 2019 | Contagion Live
  • PrEP vs. Privacy

    When you’re a young adult on your parents’ insurance, your health decisions are a family affair. And that’s a problem for HIV prevention.

    29 April 2019 | Slate
  • Ireland: Taoiseach and Minister for Health confirm introduction of PrEP programme in 2019

    Taoiseach Leo Varadkar welcomed the publication of a draft report by the Health Information and Quality Authority (HIQA) on the introduction of a pre-exposure prophylaxis (PrEP) programme aimed at preventing HIV. Health Minister Simon Harris encouraged interested parties and members of the public to give their feedback on the draft report during the consultation process which runs to 28th of May, The public consultation is at HIQA’s website:

    23 April 2019 | Irish Ministry of Health
  • Hivpoint Helsinki welcomes Pre-Exposure Prophylaxis – Finnish national guidelines are here, and generic medicines hit the market soon

    The National Institute for Health and Welfare recommends PrEP for people with a high risk for HIV transmission. As a part of a comprehensive prevention program, PrEP has reduced new HIV transmissions in all countries where it is available. When used correctly, PrEP provides up to 99% reduction in HIV risk. The Finnish national guidelines are released today, 17 April 2019.

    17 April 2019 | Hivpoint
  • Pre-Exposure Prophylaxis for HIV officially launched in Hanoi

    Pre-Exposure Prophylaxis (PrEP) service for HIV prevention was officially launched in Hanoi on April 16.

    17 April 2019 | Vietnam+
  • London councils agree to take 60% new PrEP trial patients, but it might not be enough

    A stalemate over who would take more patients on to PrEP trial has ended. London councils have agreed to increase places on city PrEP trial.

    15 April 2019 | Gay Star News
  • More Londoners to receive HIV prevention medicine

    In a boost to HIV prevention in the capital, London boroughs have agreed to provide over 4,000 extra places on the PrEP Impact Trial. The trial – a national programme led by NHS England in partnership with Public Health England and local authorities – supplies PrEP (an HIV prevention medicine) free of charge to individuals considered to be at high risk of exposure to HIV. The expansion, which will take place over the coming weeks, represents a 60% increase in the trial places available to Londoners. London already accounts for 7,609 trial places – a higher figure than the rest of England combined.

    12 April 2019 | London Councils
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.